Plasmodium vivax Malaria in Cambodia

被引：17

作者：

Siv, Sovannaroth ^{[1
]}

Roca-Feltrer, Arantxa ^{[2
]}

Vinjamuri, Seshu Babu ^{[1
]}

Bouth, Denis Mey ^{[3
]}

Lek, Dysoley ^{[1
]}

Rashid, Mohammad Abdur ^{[3
]}

By, Ngau Peng ^{[2
]}

Popovici, Jean ^{[4
]}

Huy, Rekol ^{[1
]}

Menard, Didier ^{[4
]}

机构：

[1] Natl Ctr Parasitol Entomol & Malaria Control CNM, Phnom Penh, Cambodia

[2] Malaria Consortium Cambodia, Phnom Penh, Cambodia

[3] WHO, Country Off, Phnom Penh, Cambodia

[4] IPC, Phnom Penh, Cambodia

来源：

AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE | 2016年 / 95卷 / 06期

关键词：

DIHYDROARTEMISININ-PIPERAQUINE FAILURE; FALCIPARUM-MALARIA; TRANSMISSION; ARTEMISININ; RESISTANCE; VILLAGE; ELIMINATION; CHLOROQUINE; VECTORS; QUALITY;

D O I：

10.4269/ajtmh.16-0208

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

The Cambodian National Strategic Plan for Elimination of Malaria aims to move step by step toward elimination of malaria across Cambodia with an initial focus on Plasmodium falciparum malaria before achieving elimination of all forms of malaria, including Plasmodium vivax in 2025. The emergence of artemisinin-resistant P. falciparum in western Cambodia over the last decade has drawn global attention to support the ultimate goal of P. falciparum elimination, whereas the control of P. vivax lags much behind, making the 2025 target gradually less achievable unless greater attention is given to P. vivax elimination in the country. The following review presents in detail the past and current situation regarding P. vivax malaria, activities of the National Malaria Control Program, and interventional measures applied. Constraints and obstacles that can jeopardize our efforts to eliminate this parasite species are discussed.

引用

页码：97 / 107

页数：11

共 50 条

[1] Plasmodium vivax malaria
Kochar, DK
Saxena, V
Singh, N
Kochar, SK
Kumar, SV
Das, A
EMERGING INFECTIOUS DISEASES, 2005, 11 (01) : 132 - 134
[2] Chloroquine Remains Effective for Treating Plasmodium vivax Malaria in Pursat Province, Western Cambodia
Amaratunga, Chanaki
Sreng, Sokunthea
Mao, Sivanna
Tullo, Gregory S.
Anderson, Jennifer M.
Chuor, Char Meng
Suon, Seila
Fairhurst, Rick M.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (10) : 6270 - 6272
[3] Plasmodium vivax malaria vaccines
Reyes-Sandoval, Arturo
Bachmann, Martin F.
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2013, 9 (12) : 2558 - 2565
[4] The paroxysm of Plasmodium vivax malaria
Karunaweera, ND
Wijesekera, SK
Wanasekera, D
Mendis, KN
Carter, R
TRENDS IN PARASITOLOGY, 2003, 19 (04) : 188 - 193
[5] Neonatal Plasmodium vivax malaria
Orostegui-Pinilla, D.
Rodriguez-Morales, A. J.
TROPICAL BIOMEDICINE, 2011, 28 (02) : 339 - 342
[6] CONGENITAL PLASMODIUM VIVAX MALARIA
EXCLER, JL
RENAUD, H
MONNET, P
NOUVELLE PRESSE MEDICALE, 1980, 9 (07): : 455 - 456
[7] Plasmodium vivax cerebral malaria
Thapa, Rajoo
Patra, Vikram
Kundu, Ritabrata
INDIAN PEDIATRICS, 2007, 44 (06) : 433 - 434
[8] ARDS in Plasmodium vivax malaria
Perren, A
Beretta, F
Schubarth, P
SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1998, 128 (25) : 1020 - 1023
[9] Presentation of Plasmodium vivax malaria
Jabbar, A
Shah, SMA
POSTGRADUATE MEDICAL JOURNAL, 1997, 73 (863) : 607 - 607
[10] The immunology of Plasmodium vivax malaria
Antonelli, Lis R.
Junqueira, Caroline
Vinetz, Joseph M.
Golenbock, Douglas T.
Ferreira, Marcelo U.
Gazzinelli, Ricardo T.
IMMUNOLOGICAL REVIEWS, 2020, 293 (01) : 163 - 189

← 1 2 3 4 5 →